Literature DB >> 6703385

Potentiation of neuromuscular blockade by verapamil.

N N Durant, N Nguyen, R L Katz.   

Abstract

The effects of intravenous (iv) verapamil (0.01 to 1.0 mg/kg) on the constant neuromuscular block produced by an iv infusion of either pancuronium or succinylcholine were studied on the indirectly stimulated gastrocnemius and tibialis-anterior muscles of the rabbit anesthetized with halothane in oxygen. Verapamil alone (n = 6) had no significant effect. However, the drug did significantly potentiate the 50% twitch depression of the gastrocnemius muscle produced by a constant iv infusion of either pancuronium (n = 5) or succinylcholine (n = 5) to 36 +/- 6% and 45 +/- 1% of control, respectively. This effect of verapamil occurred with doses of 0.1 mg/kg for pancuronium and 0.01 mg/kg for succinylcholine; these doses of verapamil were the lowest which produced a significant effect. In contrast, verapamil had no significant effect on the progression of the neuromuscular blockade of either the gastrocnemius or tibialis-anterior muscles produced by alpha-bungarotoxin (n = 5). Verapamil also significantly prolonged the P-R interval of the ECG from a control value of 71 +/- 2 ms to 78 +/- 3 ms at a dose of 0.1 mg/kg and to 93 +/- 6 ms at a dose of 0.3 mg/kg. The possible mechanisms of the neuromuscular actions of verapamil are discussed and it is concluded that verapamil can produce potentiation of either pancuronium- or succinylcholine-induced neuromuscular block at doses within the therapeutic range.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703385     DOI: 10.1097/00000542-198404000-00005

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  12 in total

Review 1.  Calcium-channel blockers and anaesthesia.

Authors:  P G Durand; J J Lehot; P Foëx
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

2.  Interaction of verapamil with atracurium and reversal of combined neuromuscular blockade with edrophonium and neostigmine.

Authors:  F A Wali; E McAteer; A H Suer
Journal:  Ir J Med Sci       Date:  1987-07       Impact factor: 1.568

Review 3.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

4.  Drug interactions in anaesthesia: chronic antihypertensive therapy.

Authors:  D B Craig; D Bose
Journal:  Can Anaesth Soc J       Date:  1984-09

5.  Potentiation of pancuronium induced neuromuscular blockade by calcium channel blockers in vitro.

Authors:  W Ilias; K Steinbereithner
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Calcium channel effectors are potent non-competitive blockers of acetylcholine receptors.

Authors:  L P Adam; E G Henderson
Journal:  Pflugers Arch       Date:  1990-07       Impact factor: 3.657

Review 7.  Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management.

Authors:  Mohamed Naguib; Robert Koorn
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 8.  Anaesthetic implications of calcium channel blockers.

Authors:  L C Jenkins; P J Scoates
Journal:  Can Anaesth Soc J       Date:  1985-07

9.  Effects of diltiazem and verapamil on responses to acetylcholine.

Authors:  R E Wachtel
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

Review 10.  Adverse reactions and interactions of the neuromuscular blocking drugs.

Authors:  D Ostergaard; J Engbaek; J Viby-Mogensen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.